Portuguese-Based PFx Biotech Secures €2.5M In Seed Round

The goal is to create non-GMO, allergy-free, and eco-friendly nutritional solutions for people at all life stages.

The funding round was led by Buenavista Equity Partners, with support from EIT Food and Beta Capital. This comes alongside a €2.5 million grant from the EIC Accelerator, helping PFx Biotech scale up Lactoferrin production, build dedicated labs, and expand its team.

“This is a defining moment for PFx Biotech,” said Ali Osman, Founder and CEO of PFx Biotech. “We’re proud to be backed by mission – aligned investors to help us unlock the potential of Lactoferrin in a more sustainable nutrition model. As we enter this new growth stage, we are actively exploring strategic collaborations across R&D, scale-up, and go-to-market opportunities.”

These proteins are designed for use in advanced nutrition products like infant formula, sports supplements, and elderly nutrition.

Read Also - French Startup Thunder Code Secures €7.8M Funding

The PFx team has strong expertise in dairy proteins, fermentation, molecular biology, and sustainable innovation.

Human milk proteins are considered the gold standard in early-life nutrition for their powerful health and immune-boosting benefits.

PFx Biotech is creating a new generation of these proteins—non-allergenic, non-GMO, dairy-free, and animal-free—making them easily digestible and suitable for people of all ages, including those with special dietary needs like athletes and the elderly.

“We believe PFx Biotech is one of the few companies with the scientific depth, technical execution, and visionary leadership required to make precision fermentation commercially viable at scale,” said Bibi Sattar Marques, Partner at Buenavista Equity Partners. “This investment reflects our conviction in biology-driven solutions to reshape the food system and our confidence in the PFx team to lead that change.”

As precision fermentation becomes a key technology for building sustainable and nutritious food systems, these two major milestones put PFx Biotech in a strong position to accelerate its progress and innovation in the field.

“We are not only driven by the urgent need of taking serious steps towards disrupting the current proteins production systems, but also passionate about our mission to positively impact the life of millions,” added PFx Biotech. 

About PFx Biotech

Founded in 2022, PFx Biotech is building an engineering biology platform that uses precision fermentation to produce bioactive human milk proteins at scale.